Skip to main content
. Author manuscript; available in PMC: 2021 Nov 11.
Published in final edited form as: Brain Behav Immun. 2017 Oct 23;69:57–59. doi: 10.1016/j.bbi.2017.10.020

Table 1.

Demographic and Clinical Information of 100 persons with Diagnosis of Schizophrenia or Schizoaffective Disorder.

Mean (SD)
Age (years) 32.5 (9.6)
Body Mass Index (kg/m2) (N = 97) 30.3 (6.8)
Total BPRS 31.9 (6.7)
 Positive symptoms 6.2 (3.0)
 Anxiety/Depression 5.9 (2.4)
 Hostility 4.5 (1.7)
 Negative symptoms 6.8 (2.6)
 Activation 4.0 (1.4)
% (N)
Schizophrenia 86% (N = 86)
Schizoaffective Disorder 14% (N = 14)
Gender (male) 68% (N = 68)
Race (White) 58% (N = 58)
Cigarette Smokers (N = 97) 76% (N = 74)
Antipsychotic medications
 Clozapine 40 (40%)
 Other Second Generation* 43 (43%)
 First Generation 15 (15%)
 Unknown 2 (2%)
*

Isncludes aripiprazole, paliperidone, risperidone, quetiapine, ziprasidone, olanzapine, polpharmacy, all groups < 10 per group.